The Exploration Of Targeted Anti-tumor Therapy is a research journal published by the Open Exploration Publishing Inc. The P-ISSN of this journal is .
Also, please check the following important details about exploration of targeted anti-tumor therapy: Publisher, ISSN, Ranking, Indexing, Impact Factor (if applicable), Publication fee (APC), Review Time, and Acceptance Rate.
According to Clarivate's JCR, journals indexed in SCIE/SSCI have an impact factor.
Journal Title: | Exploration of Targeted Anti-tumor Therapy |
Publisher: | Open Exploration Publishing Inc |
P-ISSN: | |
Open Access: | |
Status: | Active |
Scopus Coverage: | 2020-ongoing |
The exploration of targeted anti-tumor therapy is indexed in:
An indexed journal means that the journal has gone through and passed a review process of certain requirements done by a journal indexer.
The Web of Science Core Collection includes the Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts & Humanities Citation Index (AHCI), and Emerging Sources Citation Index (ESCI).
Based on the Official Journal Homepage, the exploration of targeted anti-tumor therapy does not charge any publication fee.
An article processing charge (APC), also known as a publication fee, is a fee which is sometimes charged to authors. Most commonly, it is involved in making a work available as open access (OA), in either a full OA journal or in a hybrid journal.
Visit to the official website of the journal/ conference to check the details about call for papers.
If your research is related to the scope of the journal, then visit the official website of exploration of targeted anti-tumor therapy and send your manuscript.
The Journal Publication Time means the average number of weeks between article submission and publication. According to the journal website, the exploration of targeted anti-tumor therapy publishes research articles in 13 weeks on an average.